Resize Text Search
  • Schedule an Appointment
  • Find a Doctor
  • Locations
Doctor Appointment
General Inquiries
 
 
 
 
 

Claims-based and Admin Quality Measures

Measure number Performance measure 2012 reporting period 2013 reporting period 2014 reporting period
ACO performance rate Mean performance rate for all ACOs ACO performance rate Mean performance rate for all ACOs ACO performance rate Mean performance rate for all ACOs
ACO #1 Getting Timely Care, Appointments, and Information - - - - 84.64 80.13
ACO #2 How Well Your Doctors Communicate - - - - 94.45 92.39
ACO #3 Patients’ Rating of Doctor - - - - 93.37 91.58
ACO #4 Access to Specialists - - - - 84.63 83.97
ACO #5 Health Promotion and Education - - - - 59.66 58.29
ACO #6 Shared Decision Making - - - - 76.32 74.60
ACO #7 Health Status/Functional Status - - - - 72.67 71.10
ACO #8 Risk Standardized, All Condition Readmissions 15.15 15.42 14.80 14.90 14.95 15.15
ACO #9 ASC Admissions: COPD or Asthma in Older Adults 1.28 1.13 1.29 1.17 1.05 1.08
ACO #10 ASC Admission: HF 0.94 1.09 1.00 1.20 0.98 1.19
ACO #11 Percent of Primary Care Providers Who Successfully Attested for the EHR Incentive Program Incentive Payment 55.66 63.37 83.59 66.21 84.68 76.71
ACO #12 Medication Reconciliation - - - - 44.24 82.61
ACO #13 Falls: Screening for Fall Risk - - - - 63.4 45.60
ACO #14 Influenza Immunization - - - - 61.31 57.51
ACO #15 Pneumococcal Vaccination - - - - 65.01 55.03
ACO #16 Adult Weight Screening and Follow-up - - - - 50.69 66.75
ACO #17 Tobacco Use Assessment and Cessation Intervention - - - - 81.19 86.79
ACO #18 Depression Screening - - - - 37.16 39.27
ACO #19 Colorectal Cancer Screening - - - - 60.79 56.14
ACO #20 Mammography Screening - - - - 54.37 61.41
ACO #21 Proportion of Adults who had blood pressure screened in past 2 years - - - - 37.83 60.24
ACO #22* Hemoglobin A1c Control (HbA1c) (<8 percent) - - - - 73.38 -
ACO #23* Low Density Lipoprotein (LDL) (< 100 mg/dL) - - - - 61.11 -
ACO #24* Blood Pressure (BP) < 140/90 - - - - 75.46 -
ACO #25* Tobacco Non-Use - - - - 73.61 -
ACO #26* Aspirin Use - - - - 89.94 -
ACO #27 Percent of beneficiaries with diabetes whose HbA1c in poor control (>9 percent) - - - - 15.17 20.35
ACO #28 Percent of beneficiaries with hypertension whose BP < 140/90 - - - - 70.64 68.02
ACO #29 Percent of beneficiaries with IVD with complete lipid profile and LDL control < 100mg/dl - - - - - -
ACO #30 Percent of beneficiaries who use Aspirin or other antithrombotic - - - - 82.24 80.79
ACO #31 Beta-Blocker Therapy for LVSD - - - - 89.86 82.71
ACO #32* Drug Therapy for Lowering LDL-Cholesterol - - - - - -
ACO #33* (ACE) Inhibitor or (ARB) Therapy for Patients with CAD and Diabetes and/or (LVSD) - - - - 82.47 -

Note: ASC = ambulatory sensitive conditions, COPD = chronic obstructive pulmonary disease, PCP = primary care physician, EHR = electronic health record, IVD = ischemic vascular disease, LVSD = left ventricular systolic dysfunction, ACE = angiotensin-converting enzyme, ARB = angiotensin receptor blocker, CAD = coronary artery disease.